Nevada proposes NAC 453.510 Schedule I additions: N‑pyrrolidino metonitazene and N‑pyrrolidino protonitazene (R038-26)

An initial draft proposed regulation (LCB File No. R038-26I) would amend NAC 453.510 (Schedule I) to add the nitazene-related substances N‑pyrrolidino metonitazene (metonitazepyne) and N‑pyrrolidino protonitazene (protonitazepyne). Compliance impact: organizations that may possess or encounter these substances in Nevada (e.g., clinical/toxicology labs, forensic labs, analytical standards suppliers, and other controlled-substance registrants) should track the rulemaking and be prepared to adjust controls and policies if these compounds become Schedule I under Nevada law.